| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 08/04/2005 | US20050172350 Identifying modulators of purine/pyrimidine phosphoribosyl transferase (PPPT) polypeptides; treating and preventing microorganismal infection in crop plants |
| 08/04/2005 | US20050172349 Genetic modification of C57 mice |
| 08/04/2005 | US20050172348 models can be used to improve diagnosis of diseases relating to energy metabolism as well as identifying and testing pharmaceutical compositions for better treatment and prevention of diseases relating to energy metabolism; transgenic mouse has an elevated glycogen content in skeletal muscle |
| 08/04/2005 | US20050172347 Using nuclear transformation to generate animal embryo; animal models; uniformity of meat product; animal management |
| 08/04/2005 | US20050172344 Using hippocampal cells as models for identifying modulators for prevention and/or treatment of nervous system disorders |
| 08/04/2005 | US20050172343 Astrocyte modulated genes and uses thereof |
| 08/04/2005 | US20050172342 Production of collagen in the milk of transgenic mammals |
| 08/04/2005 | US20050171336 Murine ortholog of the human disrupted-in-schizophrenia 1 gene |
| 08/04/2005 | US20050170330 Using transgenic angiogenic progenitor cells to diagnosis neovascularization and tumor development |
| 08/04/2005 | US20050169900 inhibit proliferation of the malignant tumor by administering to the subject a plurality of a genetically manipulated cell which expresses cytokines, cellular adhesion molecules, immunostimulants, tumor associated antigens and tumor specific antigens; biodrugs as anticarcinogenic agents |
| 08/04/2005 | US20050169840 Determining whether a factor is a modulator of the transmission of immunity from a female mammal to newborn mammals by consumption of milk from the female; BALB/C female mouse, is exposed to the factor, and then immunized to antigen(s); immunity compared between experimental and control newborns |
| 08/04/2005 | CA2552756A1 Mouse model for psoriasis and psoriatic arthritis |
| 08/03/2005 | EP1559722A1 Caenorhabditis elegans p21-activated kinase (PAK) gene and associated loss-of-function phenotypes |
| 08/03/2005 | EP1559317A1 Nonbacterial prostatitis model animal |
| 08/03/2005 | EP1558735A1 Porcine uroplakin ii promoter and the production method of useful proteins using said promoter |
| 08/03/2005 | EP0896620B1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein |
| 08/03/2005 | EP0871366B8 Food product and process |
| 08/03/2005 | EP0815231B1 Use of neuronal apoptosis inhibitor protein (naip) |
| 08/03/2005 | CN1650007A Embryonically modified animal and method of constructing the same |
| 08/03/2005 | CN1650003A A method for selecting cell lines to be used for nuclear transfer in mammalian species |
| 08/03/2005 | CN1649489A Method of constructing germline chimeric animal |
| 08/03/2005 | CN1647681A Quality improving agent for Chinese turtle and its use |
| 08/03/2005 | CN1647626A Artificial breeding and producing method for trichogramma |
| 08/03/2005 | CN1647625A Method for producing new fluorescent fish and new fluorescent fish produced by said method |
| 08/03/2005 | CN1647624A Method for fish gene in site modification breeding |
| 08/02/2005 | US6924415 Identified as a target for therapeutic intervention due to its role in molecular events that lead to or contribute to cardiac hypertrophy and/or dilated cardiomyopathy |
| 08/02/2005 | US6924414 Muir-torre-like syndrome in Fhit deficient mice |
| 08/02/2005 | US6924413 Experimental animals for evaluation of therapeutic effects on corneal epithelial damages |
| 08/02/2005 | US6924412 transgenic, non-human animal with a genome a that has stably integrated, recombinant nucleic acid encoding a polymeric immunoglobulin receptor protein linked to a mammary specific promoter |
| 08/02/2005 | US6924126 Cloning, expression and characterization of the SPG4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 08/02/2005 | US6924119 cGMP-visualizing probe and a method of detecting and quantifying of cGMP by using the same |
| 08/02/2005 | US6924100 Nucleotide sequences coding preferential polypeptide for use in the treatment and diagnosis of cardiovascular disorders and headaches |
| 08/02/2005 | US6923959 Method of pre-inducing a state of immune tolerance before organ transplantation |
| 07/28/2005 | WO2005068495A1 Silk thread containing spider thread protein and silkworm producing the silk thread |
| 07/28/2005 | WO2005067912A1 Method of intentionally, noninvasively, therapeutically modulating fat in a living mammal |
| 07/28/2005 | WO2005067798A1 Device for carrying out the minimally invasive withdrawal of blood from animals by using blood-sucking assassin bugs |
| 07/28/2005 | WO2005067710A1 Non-human mammal model comprising heterologous nucleated cells-use for screening compounds |
| 07/28/2005 | WO2005067709A2 Chimeric murine model comprising human hepatocytes user for screening compounds |
| 07/28/2005 | WO2005067708A2 Zebrafish model for autoimmune diseases |
| 07/28/2005 | WO2005041880A3 RhPV AS A MODEL FOR HPV-INDUCED CANCERS |
| 07/28/2005 | WO2005013682A3 Animal model for the analysis of tumor metastasis |
| 07/28/2005 | WO2002072028A3 Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells |
| 07/28/2005 | US20050166275 Transgenic animal model for chronic pancreatitis |
| 07/28/2005 | US20050166274 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050166273 Rat model of diabetic nephropathy |
| 07/28/2005 | US20050166272 Double stranded RNA sequences for use as models in defining and determining sequence complement necessary for RNA interfering activity; wreck and check mutational analysis; blocking agents |
| 07/28/2005 | US20050166269 Sleep genes in Drosophila and their use for the screening, diagnosis and therapy of sleep disorders |
| 07/28/2005 | US20050165219 Related to the thymic stromal cotransporter subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity |
| 07/28/2005 | US20050164291 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/28/2005 | US20050164284 Immunoglobulin composition for detection of cell death regulatory proteins; diagnosing cardiovascular, tumor, diabetic and nervous system disorders |
| 07/28/2005 | US20050164275 Phosphodiesterases |
| 07/28/2005 | US20050164263 identification of amino acid sequences and proteins related to MAP/ERK subfamily; gene chip; transgenic nonhuman animal; nucleic acid vector; expression in larynx epithelium, Wilms' tumors of the kidney, pancreas adenocarcinomas, fetal brain, and hippocampus; models for human therapeutic targets |
| 07/28/2005 | US20050164247 isolated nucleic acid molecule wherein CD4+T cells over-expressing said nucleic acid sequence exhibits a reduction in CD3 and CD28 mediated T-cell proliferation; vector and host cell transformed with said nucleic acid |
| 07/28/2005 | US20050163770 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 07/28/2005 | US20050163756 expressing a gene product in the gut of an animal by orally administering a recombinant AAV vector; effective, long-term expression systems; lactase deficiency |
| 07/28/2005 | CA2552913A1 Non-human mammal model comprising heterologous nucleated cells-use for screening compounds |
| 07/27/2005 | EP1556487A2 Transplantable cell |
| 07/27/2005 | EP1556484A2 Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model: uses in human neurological diseases |
| 07/27/2005 | EP1025236B1 Human checkpoint kinase, hcds1, compositions and methods |
| 07/27/2005 | CN2712078Y Isolating wall plate for feeding frog in pen |
| 07/27/2005 | CN1646906A Disruption of the REDK gene |
| 07/27/2005 | CN1646687A Modified gene-silencing RNA and uses thereof |
| 07/27/2005 | CN1646562A Pluripotency determining factors and uses thereof |
| 07/27/2005 | CN1644043A Culture of king crab |
| 07/27/2005 | CN1212062C Method for controlling cockroach by utilizing artificial propagation of tetrastichiclae |
| 07/27/2005 | CN1212061C Population optimization and breeding method of Gaoshan sheep |
| 07/26/2005 | US6921845 Using tumor suppressor mutants for screening modulators and/or treatment of long term memory defects and anxiety; learning enhancement |
| 07/21/2005 | WO2005065450A1 Transgenic bird and method of constructing the same |
| 07/21/2005 | WO2005028657A3 Excretable reporter systems |
| 07/21/2005 | WO2005015990A8 New diabetes type 2 animal model |
| 07/21/2005 | WO2003085095A3 Novel expressed genes |
| 07/21/2005 | US20050160485 Mouse in which genome is modified |
| 07/21/2005 | US20050160483 Glycosaminoglycan deficient proteoglycan expressed in recombinant goat; antiscarring agents and reconstructive/cosmetic surgery |
| 07/21/2005 | US20050160482 Drug screening; dopamine/neurotransmitter transporters; green/yellow/blue fluorescent protein; spectrum analysis |
| 07/21/2005 | US20050159373 Novel polypeptides, and nucleic acids encoding the same |
| 07/21/2005 | US20050158832 Secreted glycoprotein hormone fusion for use in regulating the level of red blood cells in circulation |
| 07/21/2005 | US20050158800 Detecting the expression of a G-protein coupled receptor, identifying agonists or antagonists of the receptor |
| 07/21/2005 | US20050158747 Gene therapy; microarrays |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158308 For treating, preventing, or ameliorating bone-related or cartilage-related diseases such as osteoporosis; transgenic, knock-out mammals; immunization |
| 07/20/2005 | EP1555319A2 Modified nucleic acid sequences and method to increasing mRNA levels and protein expression in cell systems |
| 07/20/2005 | EP1555317A1 Synthetic genes and genetic constructs comprising the same |
| 07/20/2005 | EP1554388A1 Transgenic expression cassettes for the expression of nucleic acids in plant blooms |
| 07/20/2005 | EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/20/2005 | EP1373545A4 Mch1r deficient mice |
| 07/20/2005 | EP1253823A4 Controlling offspring's sex ratio by targeting transgenes onto the sex chromosomes |
| 07/20/2005 | EP1222301B1 Protein production system |
| 07/20/2005 | EP0934407B1 Polycation-sensing receptor in aquatic species and methods of use thereof |
| 07/20/2005 | CN1643152A Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms |
| 07/20/2005 | CN1640890A Cell withering factor derivated from placents |
| 07/20/2005 | CN1211486C A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof |
| 07/20/2005 | CN1211010C Process for industrial production for eretmocerus SP. |
| 07/19/2005 | US6919438 Comprises viral expression vector coding envelope protein domains for use as gene therapeutic tool in the treatment of autoimmune diseases |
| 07/19/2005 | US6919206 Medium containing flt3 ligand for culturing hematophoietic cells |
| 07/19/2005 | US6919183 Detecting and isolating cells that produce preferential protein; obtain cells, transfrom cells with vector containing preferential protein, detect protein on surface of cell, isolate cells displaying preferential protein |
| 07/19/2005 | US6919177 Screening animal for preferential meat qualities; obtain tissue sample, extract nucleotide sequences, detect geneotype associated with litter size, screen for polymorphism |
| 07/19/2005 | US6918354 Method and apparatus for butane-enhanced aquatic plant and animal growth |
| 07/14/2005 | WO2005063292A2 Heh4 molecules and uses thereof |
| 07/14/2005 | WO2005063279A1 Means for stimulation and activation of hair growth by il-15 |
| 07/14/2005 | WO2005063264A1 Immunopotentiator and method of enhancing immunological activity with the same |